通过FBN1/TGF-β/Smad3通路,MFAP2促进HSCs的激活
Yonghong Sun1,2, Xingxing Chen2, Lili Chen3
1Department of Gastroenterology, The First Hospital of Lanzhou University, Lanzhou, China.
Journal of cellular and molecular medicine
|August 28, 2023
概括
微纤维相关蛋白2 (MFAP2) 通过促进肝星细胞活化和原蛋白生产,驱动肝纤维化. 抑制MFAP2显示出治疗肝纤维化和预防肝硬化的潜力.
科学领域:
- 肝病学 肝病学是一种肝病学.
- 分子生物学分子生物学
- 生物化学 生物化学
背景情况:
- 肝纤维化是一种慢性炎症状况,标志着细胞外基质的积累,可能导致肝硬化和肝癌.
- 在炎症下肝星细胞 (HSC) 的激活驱动着原体的分泌,对肝纤维化发展有显著的贡献.
研究的目的:
- 为了识别肝纤维化期间参与HSC激活的关键基因.
- 调查微纤维相关蛋白2 (MFAP2) 在肝纤维化病原发生中的作用.
主要方法:
- 对静态与纤维性HSC中的差异表达基因 (DEGs) 的基因表达综合 (GEO) 数据库的分析.
- 在体外和体内实验中使用四化碳 (CCl4) 诱导的肝纤维化模型和TGF-β1激活的HSC.
- MFAP2的淘汰和过度表达研究,以及与MFAP2与Fibrillin-1 (FBN1) 相关联的生物信息学分析.
主要成果:
- 发现MFAP2在CCl4诱导的肝纤维化和TGF-β1激活的肝纤维细胞中被上调调节.
- MFAP2的敲除抑制了HSC的扩散,并部分减少了TGF-β刺激的纤维生成标志物.
- MFAP2与纤维素-1 (FBN1) 表达正相关,MFAP2抑制通过减少HSC激活和促进亡来缓解肝纤维化.
结论:
- MFAP2通过驱动HSC激活,增殖和原沉积,在促进肝纤维化方面发挥着至关重要的作用.
- 向MFAP2为肝纤维化的临床治疗提供了一个有前途的治疗策略.
更多相关视频
08:02Isolation of Primary Cancer-Associated Fibroblasts from a Syngeneic Murine Model of Breast Cancer for the Study of Targeted Nanoparticles
Published on: May 14, 2021
5.7K
11:25FACS-Isolation and Culture of Fibro-Adipogenic Progenitors and Muscle Stem Cells from Unperturbed and Injured Mouse Skeletal Muscle
Published on: June 8, 2022
6.2K
相关概念视频
01:01Regulation of Hematopoietic Stem Cells
3.2K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.2K
01:16TGF - β Signaling Pathway
7.4K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.4K
01:07MAPK Signaling Cascades
5.6K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
5.6K
01:24Regulation of Angiogenesis and Blood Supply
2.6K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.6K
01:19Multipotency of Hematopoietic Stem Cells
3.1K
The hematopoietic stem cells or HSCs are multipotent, meaning they can differentiate and give rise to all blood and immune cells. HSCs are maintained in the quiescent stage until an external stimulus initiates their differentiation. The multipotent HSCs exist as two heterogeneous populations, long-term repopulating cells (LTRC) and short-term repopulating cells (STRC). The two HSC populations have different surface markers or receptors and are classified based on quiescence and long-term...
3.1K